3.0
Aug 31, 2012
Recommend
CEO approval
Business Outlook
Pros
Still a nice company to work for, great benefits (though they are getting worse), mostly nice and well-qualified people
Cons
Shaky pipeline, bad decision making by management - remember Famvir? No way they'll find a substitute for Diovan cash cow so it will be one lay-off afer another. The company is going down, hopefully they have enough money in Basel it keep it afloat.